Status:
COMPLETED
A Comparison of Different Fecal Occult Blood Test for Colorectal Cancer Screening
Lead Sponsor:
Shandong University
Conditions:
Colorectal Cancer
Eligibility:
All Genders
50-75 years
Brief Summary
Colorectal cancer is a leading cause of cancer-related morbidity and mortality. CRC-related death can be prevented through fecal occult blood test screening. Because of economic and high sensitivity, ...
Detailed Description
Colorectal cancer (CRC) is one of the most common cancer worldwide, and cause a huge number of cancer-associated mortality. CRC screening has been shown to be effective in reducing the incidence of, a...
Eligibility Criteria
Inclusion
- Adults 50-75 years old;
- Asia-Pacific Colorectal Screening score(APCS): medium or high risk.
Exclusion
- APCS score: low risk;
- People with history of intestinal surgery;
- People with history of CRC;
- People with history of inflammatory bowel disease, ischemic enteritis, vascular malformation of intestine or other disease resulting in intestinal tract bleeding;
- People with symptoms including visible rectal bleeding, hematuria, severe and acute diarrhea and Bristol feces score 7th type;
- Pregnancy, lactation or menstrual phase;
- Severe congestive heart failure or other sever disease cause cannot tolerate colonoscopy.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04454099
Start Date
July 1 2020
End Date
March 18 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital
Jinan, Shandong, China, 250001